BOEHRINGER-INGELHEIM
3.8.2022 12:07:11 CEST | Business Wire | Press release
Boehringer Ingelheim, a leading research-driven biopharmaceutical company, continued to increase its supply of medicine to patients in the first half of 2022, as it expanded its research pipeline in an increasingly challenging economic, political and regulatory environment.
Boehringer Ingelheim has experienced strong momentum through greater investment in Research & Development (R&D), accelerated development of its pipeline and business development opportunities. The company also closed 11 R&D partnership and license deals so far this year, with a focus on new modalities such as protein degraders, antimicrobial resistance, regenerative medicine, oncology and data science.
Fueled by ongoing strong demand for the company’s human heart failure, diabetes and respiratory treatments, and its products for pets, currency-adjusted net sales rose by 9.5 percent to 11.2 billion EUR.
“Despite a volatile economic environment, we were able to supply more patients with the treatments that make a difference to them, while advancing our pipeline in Human Pharma as well as in Animal Health striving to transform lives where medical need is high,” said Hubertus von Baumbach, Chairman of the Board of Managing Directors.
Boehringer Ingelheim has earmarked 25 billion EUR for investments in R&D and an additional 7 billion EUR for new production technologies over the next five years. The company anticipates running eight active human medicines registrational trials by the end of the year, with the potential of bringing 15 new products to patients by 2027.
“Although we expect economic uncertainties to persist in the second half of the year, we remain confident that we can achieve our goals for 2022 and proceed on our innovation-driven path,” said Michael Schmelmer, Member of the Board of Managing Directors, responsible for Finance & Group Functions. “We will continue to focus on and invest in our most promising assets to bring the best value to patients.”
Net sales in Human Pharma were up 11.8 percent (currency-adjusted) during the first six months of 2022 at 8.4 billion EUR, mainly driven by diabetes treatment of the JARDIANCE® family at 2.5 billion EUR and the respiratory medicine OFEV® at 1.5 billion EUR.
Growth in the Animal Health business amounted to 1.2 percent (currency-adjusted) to 2.4 billion EUR. The business was impacted by challenging market conditions including inflation, COVID-19 lockdowns, outbreaks of African Swine Fever and supply chain constraints. Net sales of NEXGARD® , a parasiticide for dogs, increased 13.7 percent (currency-adjusted) to 593 million EUR, while HEARTGARD® , which prevents heartworm disease in dogs, rose 4.4 percent to 197 million EUR.
For the remainder of the year Boehringer Ingelheim is anticipating regulatory updates for Spesolimab, a potential treatment for flares in generalized pustular psoriasis (GPP), a rare, life-threatening neutrophilic skin disease. The company will also present promising data on JARDIANCE® for the treatment of patients with chronic kidney disease. In addition, major product launches are expected for Animal Health in 2022 and 2023.
Click here for the full release: https://www.boehringer-ingelheim.com/about-us/corporate-profile/boehringer-ingelheim-2022-half-year-results
View source version on businesswire.com: https://www.businesswire.com/news/home/20220803005402/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Global udvider sine kompetencer i Canada med tilføjelsen af advokatfirmaet Parlee McLaws26.2.2026 16:21:00 CET | Pressemeddelelse
Andersen Global udvider sin tilstedeværelse i Canada med tilføjelsen af samarbejdsfirmaet Parlee McLaws LLP og styrker dermed sin eksisterende platform i landet med supplerende juridiske kompetencer. Parlee McLaws blev grundlagt i 1883 og tilbyder en bred vifte af juridiske ydelser, herunder selskabs- og erhvervsret, værdipapirret, retssager og tvistløsning, fast ejendom, arbejds- og ansættelsesret, immaterialret, energi, insolvens, forvaltningsret samt online brandbeskyttelse. Med sine i Edmonton og Calgary har firmaet opbygget et solidt ry for at levere praktiske, klientfokuserede løsninger, der er skræddersyet til behovene hos virksomheder og enkeltpersoner på tværs af brancher. "Vores samarbejde med Andersen Global giver vores klienter adgang til et bredere udvalg af globale ressourcer, samtidig med at vi fastholder den personlige service og dybe regionale indsigt, der kendetegner vores firma," udtaler Jerri L. Cairns, som er administrerende direktør i Parlee McLaws. "Vi ser frem t
Sitetracker Closes 2025 with Strong Momentum, Product Expansion, and a Clear Path into 202626.2.2026 15:00:00 CET | Press release
Sitetracker, the global leader in complete Asset Lifecycle Management for critical infrastructure, today announced strong year-end results for 2025, marked by continued customer growth, expansion into new infrastructure markets, and major product innovations across operations, maintenance, and financial management. As infrastructure owners and operators face growing pressure to scale without adding headcount, Sitetracker enters 2026 positioned to help customers operate smarter, move faster, and unlock greater productivity. 2025 Highlights In 2025, Sitetracker delivered another year of growth and execution across its global customer base: Customer growth and market expansion: Sitetracker now serves more than 400 customers globally, supporting organizations across digital infrastructure, renewables, EV charging, utilities, and emerging infrastructure markets including data centers. Enhanced Operations & Maintenance capabilities: Sitetracker now connects field operations and work order ma
New Lenovo Service Delivers Always-On Infrastructure: Premier Support Plus for Servers Powered by Proactive, AI-Driven Support26.2.2026 15:00:00 CET | Press release
Lenovo today announced the availability of Lenovo Premier Support Plus for Servers, a new premium support offering designed to help enterprises reduce downtime, simplify IT operations, and keep mission-critical infrastructure always ready. Built for today’s always-on environments, Premier Support Plus combines AI-driven proactive and predictive support, preventative maintenance, 24/7 access to Lenovo experts, and designated Service Engagement Managers to help organizations move from reactive issue resolution to proactive system care. As digital operations continue to expand and infrastructure environments grow more complex, IT teams are under increasing pressure to maintain uptime while managing limited resources. Traditional, reactive support models can lead to extended outages, repeated issues, and unpredictable costs. Lenovo Premier Support Plus for Servers addresses these challenges by identifying potential issues early and resolving them before they impact business operations. “Wi
Proxima Fusion, RWE, the Free State of Bavaria and Max Planck Institute for Plasma Physics Sign Agreement to Build the World’s First Commercial Fusion Power Plant in Europe26.2.2026 14:15:00 CET | Press release
Memorandum of Understanding aligns on a concrete path to building the first stellarator fusion power plant, Stellaris, in Europe. Proxima’s Alpha demonstration stellarator will first be built in Garching, while power plant Stellaris is subsequently planned for Gundremmingen. The two projects are expected to create thousands of jobs and strengthen European competitiveness and energy security. Proxima plans to finance approximately 20 percent of project costs through private investment, while Bavaria has indicated a potential state contribution of 20 percent. Proxima Fusion, Europe’s fastest-growing fusion energy company, has signed an agreement with the Free State of Bavaria, RWE, and Max Planck Institute for Plasma Physics (IPP) to put the world’s first commercial stellarator fusion power plant on the grid in Europe. Roadmap to a commercial fusion power plant begins with Alpha The Memorandum of Understanding (MoU) outlines a roadmap to commercial fusion in Europe that begins with build
NTT DATA and Ericsson Team Up to Scale Private 5G and Physical AI for Enterprises26.2.2026 14:00:00 CET | Press release
Private 5G delivered as a fully managed global service with consistent security and operations worldwide Edge AI and physical AI embedded directly into enterprise connectivity for real-time, autonomous decision-making Together, the companies help enterprises move from pilots to globally scalable, production-ready solutions NTT DATA, a global leader in AI, digital business and technology services, and Ericsson (NASDAQ: ERIC) today announced a multi-year strategic partnership to accelerate enterprise adoption of private 5G and unlock advanced edge AI and physical AI use cases. As organizations look to embed intelligence at the edge across global operations, the partnership will enable AI-driven, outcome-focused transformation. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260226356511/en/ NTT DATA x Ericsson By combining Ericsson’s Private 5G and Edge platforms with NTT DATA’s full-stack enterprise network services, wireless
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom